Results 71 to 80 of about 2,147 (178)
IL-1 Inhibition and Vascular Function in CKD [PDF]
, 2017 Vascular endothelial dysfunction and increased arterial stiffness contribute to increased cardiovascular risk in patients with CKD who exhibit chronic systemic inflammation.
Smits, G. +10 more
core +1 more source
Canakinumab i rilonacept per al tractament de les síndromes periòdiques associades a la criopirina [PDF]
, 2012 Síndromes periòdiques associades a criopirina; Canakinumab; Assaigs clínics; Rilonacept;Cryopyrin-Associates Periodic Syndrome; CAP; Clinical Trial; Síndromes periódicos asociados a criopirina; Ensayos ClínicosLes síndromes periòdiques associades a ...
Comitè d’Avaluació de Medicaments d’Ús Hospitalari (CAMUH)
core +1 more source
Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study. [PDF]
, 2015 Increased levels of markers of systemic inflammation have been associated with serious non-AIDS events even in patients on fully suppressive antiretroviral therapy.
Richard Gilson +11 more
core +2 more sources
, 2022 BackgroundThe cytokine interleukin (IL)-1 plays a pivotal role in immune-mediated disorders, particularly in autoinflammatory diseases. Targeting this cytokine proved to be efficacious in treating numerous IL-1-mediated pathologies. Currently, three IL-1
Dennis D. Arnold (13003734) +2 more
core +1 more source
Anti-Interleukin-1 Agents in Adult Onset Still's Disease
International Journal of Inflammation, 2012 Interleukin 1β (IL-1β) is emerging as a master mediator of adult onset Still’s disease (AOSD) pathogenesis. This pleiotropic cytokine, whose expression is under the control of the inflammasome pathway, has a wide type of effects.
Cecilia Giampietro, Bruno Fautrel
doaj +1 more source
, 2022 BackgroundThe cytokine interleukin (IL)-1 plays a pivotal role in immune-mediated disorders, particularly in autoinflammatory diseases. Targeting this cytokine proved to be efficacious in treating numerous IL-1-mediated pathologies. Currently, three IL-1
Dennis D. Arnold (13003734) +2 more
core +1 more source
Muckle–Wells syndrome: clinical perspectives
Open Access Rheumatology: Research and Reviews, 2017 Tu-Anh Tran Department of Pediatrics, Nîmes University Hospital, INSERM U1183, Montpellier-Nîmes University, Nîmes, France Abstract: Muckle–Wells syndrome (MWS) is a rare autoinflammatory disorder.
Tran TA
doaj
Clinical Immunology CommunicationsDeficiency of Interleukin-1 receptor antagonist (DIRA) is a rare autosomal recessive autoinflammatory disease first reported in 2009. To date, 33 patients have been previously characterized and reported in literature.
Spencer Fang +2 more
doaj +1 more source
Alveolar IL1β+ neutrophils: Emerging biomarkers and therapeutic targets in CARDS progression
Clinical and Translational Discovery, Volume 5, Issue 5, October 2025.
Lu Jia, Ying Tang, Jianfeng Xie
wiley +1 more source
, 2022 BackgroundThe cytokine interleukin (IL)-1 plays a pivotal role in immune-mediated disorders, particularly in autoinflammatory diseases. Targeting this cytokine proved to be efficacious in treating numerous IL-1-mediated pathologies. Currently, three IL-1
Dennis D. Arnold (13003734) +2 more
core +1 more source